On the basis of the difference in MPC expression between OxPhos- and BCR-DLBCL subgroups, we initially set out to study potential differences in the utilization of mitochondrial pyruvate in these cell types. The gene discussed is BCR; the disease is diffuse large B-cell lymphoma.